Table 4. Summary of case reports of rivaroxaban-based triple antithrombotic treatment of post-AMI LVT.
| No. | Author | Etiology | Thrombus | HAS-BLED | Regimen | Outcome | Adverse event | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shape | Location | Size (mm2) | Rivaroxaban (mg) | Duration (month) | Adjunctive antiplatelet agents | ||||||
| 1 | Abdelnaby M (24) | NSTEMI | – | 10×10 | 2 | 15 | 3 | Aspirin 100 mg + clopidogrel 75 mg | Resolved | None | |
| 2 | STEMI | 12×5 | 2 | 15 | 3 | Resolved | None | ||||
| 3 | STEMI | 13×7 | 2 | 20 | 3 | Resolved | None | ||||
| 4 | STEMI | 14×7 | 2 | 20 | 3 | Resolved | None | ||||
| 5 | STEMI | 8×2 | 1 | 15 | 3 | Resolved | None | ||||
| 6 | STEMI | 10×6 | 2 | 15 | 3 | Resolved | None | ||||
| 7 | NSTEMI | 12×10 | 2 | 15 | 3 | Residual | None | ||||
| 8 | NSTEMI | 12×12 | 1 | 20 | 3 | Resolved | None | ||||
| 9 | Makrides CA (30) | STEMI | – | – | – | 1 | 15 | 3 | Aspirin 100 mg + clopidogrel 75 mg | Resolved | None |
| 10 | STEMI | pedunculated | Apex | 17×16 | 2 | 15 | 3 | Aspirin 75 mg + clopidogrel 75 mg | Resolved | None | |
| 11 | STEMI | elongated | Apex | – | 2 | 15 | 3 | Aspirin 75 mg + clopidogrel 75 mg | Resolved | None | |
| 12 | Shokr M (31) | STEMI | Protrusion | Apex | 38×18 | 1 | 15–20 | 3 | Aspirin 100 mg + clopidogrel 75 mg | Resolved | None |
| 13 | STEMI | mural | Septal | 12×9 | 1 | 20 | 4 | Resolved | None | ||
| 14 | STEMI | – | Apex | 18×8 | 2 | 20 | 3 | Resolved | None | ||
| 15 | ICM | – | Apex | 13×11 | 3 | 20 | 6 | Resolved | GI bleeding | ||
| 16 | Seecheran R (32) | STEMI | Protrusion | Apex | 25×15 | 1 | 20 | 3 | Aspirin 81 mg + ticagrelor 90 twice daily | Resolved | None |
| 17 | Summaria F (33) | NSTEMI | Masses | Apex | – | 3 | 15 | 6 | Aspirin 100 mg + clopidogrel 75 mg | Resolved | None |
| 18 | Azizi A (34) | STEMI | – | Apex | – | 1 | 20 | 3 | Aspirin 100 mg + clopidogrel 75 mg | Resolved | None |
| 19 | Smetana KS (35) | STEMI | mural | Apex | – | – | 20 | – | Aspirin + clopidogrel | – | – |
| 20 | NSTEMI | – | – | 10×10 | 15 twice–20 daily | Aspirin + clopidogrel | Residual | None | |||
| 21 | NSTEMI | Small | Apex | – | 15 twice–20 daily | Aspirin + clopidogrel | Resolved | None | |||
STEMI, ST-elevation myocardial infarction; NSTEMI, non-ST-elevation myocardial infarction; ICM, ischemic cardiomyopathy; GI, bleeding gastrointestinal bleeding.